Atlas Trials

Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center

6 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center

RecordFirmDate
Adaptive Neoadjuvant Therapy for Esophageal Cancer (NCT06990178)Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center2028-03-01
A Prospective, Single-arm, Phase II Clinical Trial of Becotatug Vedotin for Injection Combined With Pucotenlimab Injection as a First-line Treatment for Platinum-intolerant Advanced Head and Neck Squamous Cell Carcinoma (NCT07628855)Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center2026-05-14
Exploratory Clinical Study of Personalized mRNA Tumor Vaccine RH125 in Patients With Advanced Solid Tumors (NCT07182435)Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center2025-09-15
A Phase Ib/II Study of Adebrelimab in Combination with Capecitabine and Oxaliplatin in Cancer (NCT06776770)Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center2024-08-03
Sintilimab in Combination with Cetuximab and Chemotherapy As First-line Treatment for RAS/BRAF Wild-type Advanced Colorectal Cancer (NCT06776757)Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center2023-12-25
Surgical Resection Enhances Survival in Gastric-type Endocervical Adenocarcinoma: A SEER-Based Study (NCT07026825)Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center2000-01-01

Track Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center automatically

Every clearance here is in the API, with alerts when new ones post.